We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Pooled Sputum Testing Offers Lower-Cost Molecular Diagnosis for Tuberculosis

By LabMedica International staff writers
Posted on 08 Oct 2026

Tuberculosis remains a major diagnostic challenge, with many cases going undetected and untreated. More...

Limited access to rapid molecular diagnostic tests can delay diagnosis and allow transmission to continue in homes and communities. Global TB control is further constrained by chronic underinvestment and inequitable testing access. Against this backdrop, researchers now present evidence that pooled sputum testing could expand access to rapid, lower-cost TB diagnosis.

Liverpool School of Tropical Medicine (LSTM) led the Start4All study, a four-year Unitaid-funded partnership with the Stop TB Partnership and research partners in seven high TB-burden countries. The study evaluated pooled sputum testing for tuberculosis using Cepheid's Xpert MTB/RIF Ultra. The method examines sputum specimens from several people in a single molecular test cartridge, with each person’s sample also tested individually.

Between November 2023 and February 2025, more than 14,000 people with symptoms of TB participated in Bangladesh, Brazil, Cameroon, Kenya, Malawi, Nigeria, and Vietnam. Screening took place in communities, primary health centers, and district hospitals. Each sputum specimen was tested alone and again as part of a pool of up to four specimens. The study was described as the first to measure pooled testing against culture, the reference standard for TB diagnosis, rather than only against individual molecular testing.

Pooled testing used just over 7,000 cartridges instead of roughly 14,000 required for individual testing, representing a 51% reduction. The cost of each test fell from nearly USD 8 to less than USD 4. Sensitivity was 3.1% lower than individual testing, mainly in specimens with very low TB bacterial load. The findings were published in The Lancet Global Health on September 24, 2026, and directly informed World Health Organization guidelines on pooled testing issued earlier this year.

The work is part of a series of Start4All outputs on pooled testing, including publications in The Lancet Respiratory Medicine, BMJ Open, and Clinical Microbiology and Infection. The source also states that a toolkit, a test cost calculator, and a decision tool have been developed for healthcare professionals and National TB Programmes. In the next phase of Start4All, pooled testing will be combined with computer-aided chest X-ray triage and expanded to tongue swab specimens.

“This is the evidence that took pooled testing from a promising idea to a WHO recommendation, and it comes from routine laboratories and clinics in the countries that need it most, not from a research setting. Pooling needs no new technology. It makes smarter use of the machines and cartridges laboratories already have, so that many more people can receive a rapid molecular test from the same budget. That is what reaching the missed millions looks like in practice,” said Dr. Tom Wingfield, deputy director of LSTM’s Centre for Tuberculosis Research and chief investigator on Start4All.

Related Links
Liverpool School of Tropical Medicine


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
New
Connectivity Solution
EKF Link
Gold Member
Automatic Hematology Analyzer
CF9600
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The MIRAM GAGome Kit quantifies urine CS disaccharides by UHPLC-MS/MS, supporting exploratory and translational research across disease areas. (Photo courtesy of Elypta)

Study Finds Urine Biomarker Score Improves Five-Year Cancer Risk Prediction

Cancer risk stratification in healthy adults often relies on established factors such as age and smoking history. However, several cancers highlighted in the study, including pancreatic, kidney, and brain... Read more

Hematology

view channel
Image: These new ANC reference ranges can help clinicians more accurately interpret neutrophil counts, reduce unnecessary testing and treatment interruptions, and help support more equitable care. (Photo courtesy of the American Society of Hematology)

New Reference Ranges Clarify Normal Neutrophil Counts in Duffy-Null Patients

Duffy-null status is a common genetic trait associated with naturally lower circulating white blood cell counts. It affects about 10% of the U.S. population and more than 66% of people with African or... Read more

Immunology

view channel
Image: The panel expands Cepheid’s respiratory testing portfolio on the GeneXpert platform, offering laboratories greater flexibility in selecting tests based on clinical needs. (Photo courtesy of Cepheid)

Multiplex PCR Test Gains CE Marking to Support Respiratory Infection Diagnosis

Acute respiratory infections often present with overlapping symptoms, making it difficult to distinguish between viral and bacterial causes. Seasonal surges of influenza-like illness in Europe further... Read more

Microbiology

view channel
Image: VITEK PRO combines microbial identification and antimicrobial susceptibility testing on a single platform to support routine microbiology workflows and antibiotic selection. (Photo courtesy of bioMérieux)

Automated Microbial Identification and Susceptibility System Gains FDA Clearance

Antimicrobial resistance (AMR) is a leading global public health threat, causing an estimated 1.27 million deaths annually. The growing challenge of diagnosing and treating resistant infections highlights... Read more

Pathology

view channel
AI: Artificial intelligence; CNN: Convolutional neural networks; ResNet: Residual neural network. (Xing-hua Gao from The First Hospital of China Medical University, China Image Source Link: https://www.ovid.com/jnls/cmj/fulltext/10.1097/cm9.0000000000004154~deep-learning-based-computational-pathology-technologies)

Review Highlights Progress and Validation Needs for AI in Digital Pathology

Pathology remains the gold standard for disease diagnosis, but clinical laboratories face growing demands for faster, more reproducible diagnostic and prognostic workflows. Digital pathology based on whole-slide... Read more

Industry

view channel
Image: The collaboration aims to expand access to the technology through a regulated clinical diagnostics pathway in Japan.

Partnership Aims to Bring Blood-Based Alzheimer’s Testing to Japan

Alzheimer’s disease remains a growing diagnostic challenge as populations age and cognitive impairment becomes more common. In Japan, government-supported estimates project that approximately 4.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.